Table 1.
Participants’ characteristics at baseline
| Characteristic | n = 16 |
|---|---|
| Female | 9 (56%) |
| Age (years) | 59 ± 7 |
| Weight (kg) | 87 ± 28 |
| Height (cm) | 159 ± 10 |
| Body mass index (kg/m2) | 34 ± 7 |
| Waist circumference (cm) | 110 ± 27 |
| Smoking | |
| Active smoker | 2 (12%) |
| Former smoker | 7 (44%) |
| NYHA functional classification | |
| II | 12 (75%) |
| III | 4 (25%) |
| Comorbidities | |
| Hypertension | 16 (100%) |
| Diabetes | 7(44%) |
| Rheumatic disease (gout) | 2 (12%) |
| Atrial fibrillation | 1 (6%) |
| CRF | 4 (25%) |
| AMI | 2 (12%) |
| Stroke | 3 (19%) |
| Medications | |
| ACEI/ARA | 16 (100%) |
| Beta-blockers | 13 (81%) |
| Diuretics | 13 (81%) |
| Calcium channel blockers | 11 (69%) |
| Statins | 10 (62%) |
| Antiplatelets | 9 (56%) |
| Vasodilators | 7 (44%) |
| Hypoglycemic drugs | 7 (44%) |
Values are described as mean ± standard deviation or absolute frequency (percentage). Former smoker: more than 1 year without smoking; NYHA: New York Heart Association; CRF: chronic renal failure; AMI: acute myocardial infarction; ACEI: angiotensin-converting enzyme inhibitors; ARA: angiotensin receptor antagonists.